“Multiple myeloma red flag”的搜索结果，显示 251-260 项，共有 11005 项

1. Peripheral T-cell lymphoma

   A biopsy is a procedure to remove a sample of tissue for testing in a lab. Your healthcare professional may take out a small sample or multiple samples of the ...

2. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   KTX-100 MMSET Catalytic Inhibitor that Suppresses H3K36me2 in Patients with Relapsed and Refractory Multiple Myeloma. Rochester, Minn., Jacksonville, Fla ...

3. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   Alternate Doses And Dosing Schedules Of Belantamab Mafodotin For The Treatment Of Triple-Class Recurrent And/or Refractory Multiple Myeloma. Jacksonville ...

4. 神经科- 临床试验- 妙佑医疗国际

   ... multiple myeloma. Also eligible are (11) up to 6 donors with triple negative breast cancer and (12) up to 6 donors with colorectal cancer who have no ...

5. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   A Study To Evaluate APG2575 Combined With Novel Therapeutic Regimens To Treat Subjects With Relapsed Or Refractory Multiple Myeloma And Immunoglobulin Light ...

6. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   ... multiple myeloma. Also eligible are (11) up to 6 donors with triple negative breast cancer and (12) up to 6 donors with colorectal cancer who have no ...

7. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   KTX-100 MMSET Catalytic Inhibitor that Suppresses H3K36me2 in Patients with Relapsed and Refractory Multiple Myeloma. Rochester, Minn., Jacksonville, Fla ...

8. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   Alternate Doses And Dosing Schedules Of Belantamab Mafodotin For The Treatment Of Triple-Class Recurrent And/or Refractory Multiple Myeloma. Jacksonville ...

9. 血液科- 临床试验- 妙佑医疗国际

   A Study of JNJ‐68284528 Out‐of‐Specification (OOS) for Commercial Release in Patients with Multiple Myeloma. Rochester, Minn. The purpose of this study is to ...

10. Mayo Clinic Cancer Physician Update - March 2026

    Page 1.